FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2902415094> ?p ?o ?g. }

• W2902415094 endingPage "215" @default.
• W2902415094 startingPage "212" @default.
• W2902415094 abstract "We describe the discovery and optimization of 5-substituted-N-pyridazinylbenzamide derivatives as potent and selective LRRK2 inhibitors. Extensive SAR studies led to the identification of compounds 18 and 23, which demonstrated good in vitro pharmacokinetic profile and excellent selectivity over 140 other kinases. Both compounds demonstrated high unbound fractions in both blood and brain. Compound 18 proved to be brain penetrant, and the high unbound fraction of compound 18 in brain enabled its in vivo efficacy in CNS, wherein a significant inhibition of LRRK2 Ser935 phosphorylation was observed in rat brain following intravenous infusion at 5 mg/kg/h." @default.
• W2902415094 created "2018-12-11" @default.
• W2902415094 creator A5000331660 @default.
• W2902415094 creator A5000510528 @default.
• W2902415094 creator A5002264412 @default.
• W2902415094 creator A5007482276 @default.
• W2902415094 creator A5009887419 @default.
• W2902415094 creator A5012625397 @default.
• W2902415094 creator A5022587232 @default.
• W2902415094 creator A5030274345 @default.
• W2902415094 creator A5031069096 @default.
• W2902415094 creator A5031887729 @default.
• W2902415094 creator A5034121963 @default.
• W2902415094 creator A5034357412 @default.
• W2902415094 creator A5035825835 @default.
• W2902415094 creator A5037458498 @default.
• W2902415094 creator A5041909769 @default.
• W2902415094 creator A5045492508 @default.
• W2902415094 creator A5045660596 @default.
• W2902415094 creator A5053408073 @default.
• W2902415094 creator A5063643883 @default.
• W2902415094 creator A5064842058 @default.
• W2902415094 creator A5074665087 @default.
• W2902415094 creator A5076324765 @default.
• W2902415094 date "2019-01-01" @default.
• W2902415094 modified "2023-10-09" @default.
• W2902415094 title "5-Substituted-N-pyridazinylbenzamides as potent and selective LRRK2 inhibitors: Improved brain unbound fraction enables efficacy" @default.
• W2902415094 cites W1479935944 @default.
• W2902415094 cites W1626583747 @default.
• W2902415094 cites W1979189217 @default.
• W2902415094 cites W1987160330 @default.
• W2902415094 cites W2004536040 @default.
• W2902415094 cites W2021052428 @default.
• W2902415094 cites W2041890817 @default.
• W2902415094 cites W2063127941 @default.
• W2902415094 cites W2073954164 @default.
• W2902415094 cites W2134829539 @default.
• W2902415094 cites W2145005920 @default.
• W2902415094 cites W2259808367 @default.
• W2902415094 cites W2480556520 @default.
• W2902415094 cites W2516348886 @default.
• W2902415094 cites W2569121451 @default.
• W2902415094 cites W2582072048 @default.
• W2902415094 cites W2593373447 @default.
• W2902415094 cites W2738984982 @default.
• W2902415094 cites W2753051298 @default.
• W2902415094 cites W4211044101 @default.
• W2902415094 doi "https://doi.org/10.1016/j.bmcl.2018.11.054" @default.
• W2902415094 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30522952" @default.
• W2902415094 hasPublicationYear "2019" @default.
• W2902415094 type Work @default.
• W2902415094 sameAs 2902415094 @default.
• W2902415094 citedByCount "11" @default.
• W2902415094 countsByYear W29024150942019 @default.
• W2902415094 countsByYear W29024150942020 @default.
• W2902415094 countsByYear W29024150942022 @default.
• W2902415094 countsByYear W29024150942023 @default.
• W2902415094 crossrefType "journal-article" @default.
• W2902415094 hasAuthorship W2902415094A5000331660 @default.
• W2902415094 hasAuthorship W2902415094A5000510528 @default.
• W2902415094 hasAuthorship W2902415094A5002264412 @default.
• W2902415094 hasAuthorship W2902415094A5007482276 @default.
• W2902415094 hasAuthorship W2902415094A5009887419 @default.
• W2902415094 hasAuthorship W2902415094A5012625397 @default.
• W2902415094 hasAuthorship W2902415094A5022587232 @default.
• W2902415094 hasAuthorship W2902415094A5030274345 @default.
• W2902415094 hasAuthorship W2902415094A5031069096 @default.
• W2902415094 hasAuthorship W2902415094A5031887729 @default.
• W2902415094 hasAuthorship W2902415094A5034121963 @default.
• W2902415094 hasAuthorship W2902415094A5034357412 @default.
• W2902415094 hasAuthorship W2902415094A5035825835 @default.
• W2902415094 hasAuthorship W2902415094A5037458498 @default.
• W2902415094 hasAuthorship W2902415094A5041909769 @default.
• W2902415094 hasAuthorship W2902415094A5045492508 @default.
• W2902415094 hasAuthorship W2902415094A5045660596 @default.
• W2902415094 hasAuthorship W2902415094A5053408073 @default.
• W2902415094 hasAuthorship W2902415094A5063643883 @default.
• W2902415094 hasAuthorship W2902415094A5064842058 @default.
• W2902415094 hasAuthorship W2902415094A5074665087 @default.
• W2902415094 hasAuthorship W2902415094A5076324765 @default.
• W2902415094 hasConcept C112705442 @default.
• W2902415094 hasConcept C118792377 @default.
• W2902415094 hasConcept C11960822 @default.
• W2902415094 hasConcept C150903083 @default.
• W2902415094 hasConcept C161790260 @default.
• W2902415094 hasConcept C184235292 @default.
• W2902415094 hasConcept C185592680 @default.
• W2902415094 hasConcept C202751555 @default.
• W2902415094 hasConcept C207001950 @default.
• W2902415094 hasConcept C55493867 @default.
• W2902415094 hasConcept C71924100 @default.
• W2902415094 hasConcept C86803240 @default.
• W2902415094 hasConcept C98274493 @default.
• W2902415094 hasConceptScore W2902415094C112705442 @default.
• W2902415094 hasConceptScore W2902415094C118792377 @default.
• W2902415094 hasConceptScore W2902415094C11960822 @default.
• W2902415094 hasConceptScore W2902415094C150903083 @default.
• W2902415094 hasConceptScore W2902415094C161790260 @default.

• next